Cover Image
市場調查報告書

英國的培養皮膚(皮膚替代品)市場預測

United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020

出版商 GlobalData 商品編碼 316783
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
英國的培養皮膚(皮膚替代品)市場預測 United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日期: 2014年10月15日 內容資訊: 英文 46 Pages
簡介

本報告提供英國的培養皮膚(皮膚替代品)市場相關調查分析,提供您各市場區隔的市場規模資料,年度的市場收益·數量·平均銷售價格,企業佔有率·流通佔有率資料,主要企業簡介等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 英國的培養皮膚(皮膚替代品)市場

  • 培養皮膚(皮膚替代品)市場,英國,收益實際成果($m)
  • 培養皮膚(皮膚替代品)市場,英國,收益預測($m)
    • 生物學的皮膚替代品市場,英國,收益實際成果($m),各市場區隔
    • 生物學的皮膚替代品市場,英國,收益預測($m),各市場區隔
  • 培養皮膚(皮膚替代品)市場,英國,數量實際成果
  • 培養皮膚(皮膚替代品)市場,英國,數量預測
    • 生物學的皮膚替代品市場,英國,數量實際成果,各市場區隔
    • 生物學的皮膚替代品市場,英國,數量預測,各市場區隔
  • 培養皮膚(皮膚替代品)市場,英國,平均銷售價格($)
  • 培養皮膚(皮膚替代品)市場,英國,各收益的流通佔有率($m)
  • 培養皮膚(皮膚替代品)市場,英國,各收益的企業佔有率($m)

第4章 英國的主要企業概要,培養皮膚(皮膚替代品)市場

  • Organogenesis, Inc.
  • Smith & Nephew Plc
  • Molnlycke Health Care AB
  • BSN medical GmbH
  • Covidien plc

第5章 附錄

目錄
Product Code: GDMECC0860DB

GlobalData's new report, "United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the United Kingdom Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Tissue Engineered - Skin Substitutes.
  • Key players covered include Organogenesis, Inc., Smith & Nephew Plc and Molnlycke Health Care AB.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered - Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered - Skin Substitutes Market, United Kingdom

  • 3.1. Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), 2005-2013
  • 3.2. Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), 2013-2020
    • 3.2.1. Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2005-2013
    • 3.2.2. Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2013-2020
  • 3.3. Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), 2005-2013
  • 3.4. Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), 2013-2020
    • 3.4.1. Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2005-2013
    • 3.4.2. Biologic Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2013-2020
  • 3.5. Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), 2005-2020
  • 3.6. Tissue Engineered - Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), 2012-2013
  • 3.7. Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), 2012-2013

4. Overview of Key Companies in United Kingdom, Tissue Engineered - Skin Substitutes Market

  • 4.1. Organogenesis, Inc.
    • 4.1.1. Company Overview
  • 4.2. Smith & Nephew Plc
    • 4.2.1. Company Overview
  • 4.3. Molnlycke Health Care AB
    • 4.3.1. Company Overview
  • 4.4. BSN medical GmbH
    • 4.4.1. Company Overview
  • 4.5. Covidien plc
    • 4.5.1. Company Overview

5. Appendix

  • 5.1. Research Methodology
    • 5.1.1. Coverage
    • 5.1.2. Secondary Research
    • 5.1.3. Primary Research
    • 5.1.4. Market Modeling and Forecasting
    • 5.1.5. Company Share Analysis
    • 5.1.6. Distribution Share Analysis
  • 5.2. Expert Panel
  • 5.3. GlobalData Consulting
  • 5.4. Contact Us
  • 5.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Table 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Table 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Historic, 2005-2013
  • Table 14: Tissue Engineered - Skin Substitutes Market, United Kingdom, Average Price ($), Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 17: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 2: Tissue Engineered - Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 3: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 4: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 5: Biologic Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 6: Allograft Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 7: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 8: Tissue Engineered - Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 9: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 10: Allograft Market, United Kingdom, Volume (Units), Historic, 2005-2013
  • Figure 11: Biologic Skin Substitutes Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 12: Allograft Market, United Kingdom, Volume (Units), Forecast, 2013-2020
  • Figure 13: Tissue Engineered - Skin Substitutes Market, United Kingdom, Company Share (%), 2013
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top